Fractyl Health, Inc.

Healthcare · Biotechnology · United States

Last price 0.9765 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 12.95M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably alteri...